General MedicationsORALStandard
PREZCOBIX
DARUNAVIR AND COBICISTAT
Standard Dose
600MG/90MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PREZCOBIX is listed in Drugs@FDA under application 220092 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DARUNAVIR AND COBICISTAT Form and strength TABLET, FOR SUSPENSION;ORAL - 600MG/90MG Sponsor JANSSEN PRODS Submission history Latest submission status date: 2026-02-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview PREZCOBIX is listed in Drugs@FDA under application 220092 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DARUNAVIR AND COBICISTAT Form and strength TABLET, FOR SUSPENSION;ORAL - 600MG/90MG Sponsor JANSSEN PRODS Submission history Latest submission status date: 2026-02-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.